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Summary Background. The currently used patch test concentration for formaldehyde is 1.0%
(wt/vol) in water. However, clinical experience and previous studies suggest that 1.0%
might be insufficient for detecting an optimized number of clinically relevant cases of
contact allergy to formaldehyde.
Objectives. To validate earlier patch test results for comparison of 1% (wt/vol) and 2%
(wt/vol) formaldehyde in water, and to investigate co-reactivity with quaternium-15.
Materials and methods. In 12 dermatology clinics, 3591 patients were routinely
patch tested simultaneously with 2.0% (wt/vol) (0.60 mg/cm2) and 1.0% (wt/vol)
(0.30 mg/cm2) formaldehyde. Micropipettes were used for delivering the exact dosage of
the allergen.
Results. Significantlymore patients reacted to 2.0% formaldehyde than to 1.0% (3.4%
versus 1.8%, p < 0.001). Overall, there were no sex differences between those reacting
positively to 2.0% and 1.0%. Of 25 quaternium-15-positive patients, 4 (0.1%) reacted
positively without reacting to formaldehyde.
Conclusion. On the basis of the results of this multicentre study, as well as of previous
studies, it can be suggested that 2.0% (wt/vol) in water formaldehyde should be used in
routine patch testing in the baseline series.
Key words: contact allergy; dose; false-negative; formaldehyde; micropipette; patch
test.
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cases of contact allergy to formaldehyde. Furthermore,
patch test reactions to formaldehyde have been regarded
as difficult to judgewith respect to false-positive reactions,
that is, irritant reactions, and patch test concentrations
were therefore gradually reduced from4–5%to1% (1,2).
When different patch test concentrations are compared,
it is important to ascertain that the dose is the same in
all patch tested patients. This means that, when a certain
patch test system is used, and the concentration of the
test substance in the patch test preparation is known,
the amount of the patch test preparation must be the
same in the tested patients. For liquids, a micropipette
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ensures the exact dosage (3). In a recent study, 2.0%
and 1.0% were compared by the use of parallel patch
testing with 15 μl of formaldehyde 2.0% and 1.0% in
Finn Chambers® in the baseline series. It was concluded
that patch testing with 2.0% detected significantly more
patients than patch testing 1.0% (4). Furthermore, a sig-
nificant number of patients who reacted to 2.0% but not
to 1.0% developed dermatitis in a repeated open applica-
tion test (5). The present multicentre study evaluated the
earlier findings,with the use of amicropipette to ascertain
an exact dose of the contact allergen, with respect to
an optimized patch test concentration. The relationship
between positive reactions to formaldehyde and those
to the formaldehyde-releaser quaternium-15, which is
currently part of the European baseline series, was also
investigated (6).
Materials and Methods
Aqueous solutions with formaldehyde 2.0% (wt/vol)
and 1.0% (wt/vol) were prepared from formaldehyde
37% (wt/wt) aqua obtained from Acros Organics (Geel,
Belgium). All patch test solutions were manufactured
at the laboratory in the Department of Occupational
and Environmental Dermatology in Malmo¨, Sweden,
and distributed to the participating clinics every 10th
week, that is, five times. Glass containers (13 ml)
with Teflon caps were filled with the solutions, and
distributed to the participating clinics: 11 dermatology
clinics in Europe, and one in the United States. All
participating clinics used micropipettes to obtain the
correct test dose (0.60 and 0.30 mg/cm2, respectively);
15 μl for Finn Chambers® and 20 μl for van der Bend®
chambers (3). For quaternium-15 in petrolatum, 20 mg
is recommended for Finn Chambers® (7). The patch test
preparations of quaternium-15 1% pet. were obtained
fromChemotechniqueDiagnosticsAB(Vellinge,Sweden).
Patch testing and reading days were in accordance with
the routines of the participating clinics. The reading days
differed, and for reporting the results they were classified
as follows: reading days 2–4, reading 1; and reading
days 5–8, reading 2. This means that, even if there have
been two to three readings, data in the compilation from
all clinicsmightshowupasmissingreading2.Evaluations
of themorphology of the patch test resultswere performed
according to the recommendations of the International
Contact Dermatitis ResearchGroup (8). The patch testing
took place between 1 July 2009 and 31 January 2010.
High-performance liquidchromatographywasused for
analyses of formaldehyde content prior to the distribution
of the patch test solutions (9).
Results
The results from 3591 (66.7% females) routinely patch
tested patients in the 12 participating clinics are shown
in Table 1. In this multicentre study 122 patients (3.4%)
were diagnosed with contact allergy to formaldehyde by
patch testing with 2.0%, and 66 patients (1.8%) were
diagnosed by patch testing with 1.0%. Only 4 (0.1%)
patients reacted positively to 1.0% without reacting
positively to 2.0%. The proportions of cases reacting
to formaldehyde varied between the participating clinics.
The lowest proportion among patients reacting positively
Table 1. Positive reactions to formaldehyde 2.0% (wt/vol) and 1.0% (wt/vol) when tested simultaneously in 3591 patients in 12 dermatology
clinics
2.0% positive (%)a 1.0% positive (%)a
Total tested Females All Females Males All Females Males 2.0%/1.0% b
Amsterdam, The Netherlands 684 461 (67.4) 19 (2.8) 13 (2.8) 6 (2.7) 8 (1.2) 6 (1.3) 2 (0.9) 2.4
Barcelona, Spain 269 188 (69.9) 7 (2.6) 5 (2.7) 2 (2.5) 6 (2.2) 4 (2.1) 2 (2.5) 1.2
Coimbra, Portugal 149 114 (76.5) 5 (3.4) 5 (4.4) 0 (0) 1 (0.7) 1 (0.9) 0 (0) 5.0
Copenhagen (Bispebjerg), Denmark 203 142 (70.0) 11(5.4) 6 (4.2) 5 (8.2) 5 (2.5) 2 (1.4) 3 (4.9) 2.2
Copenhagen (Gentofte), Denmark 382 260 (68.0) 13 (3.4) 7 (2.7) 6 (4.9) 9 (2.4) 6 (2.3) 3 (2.5) 1.4
Helsinki, Finland 59 30 (50.8) 7 (11.9) 4 (13.3) 3 (10.3) 5 (8.5) 3 (10) 2 (6.9) 1.4
Leuven, Belgium 228 159 (69.7) 9 (3.9) 5 (3.1) 4 (5.8) 8 (3.5) 7 (4.4) 1 (1.4) 1.1
London, United Kingdom 845 540 (63.9) 24 (2.8) 19 (3.5) 5 (1.6) 7 (0.8) 5 (0.9) 2 (0.7) 3.4
Malmo¨, Sweden 346 233 (67.3) 16 (4.6) 12 (5.2) 4 (3.5) 11 (2.9) 8 (3.4) 3 (2.7) 1.5
Odense, Denmark 202 128 (63.4) 7 (3.4) 6 (4.7) 1 (1.4) 3 (1.5) 2 (1.6) 1 (1.4) 2.3
San Francisco, United States 150 85 (56.7) 2 (1.3) 1 (1.2) 1 (1.5) 1 (0.7) 1 (1.2) 0 (0) 2.0
Strasbourg, France 74 54 (73.0) 2 (2.7) 1 (1.9) 1 (5.0) 2 (2.7) 1 (1.9) 1 (5.0) 1.0
Total 3591 2394 (66.7) 122 (3.4) 84 (3.5) 38 (3.2) 66 (1.8) 46 (1.9) 20 (1.7) 1.8
aFor all positives, a reaction on an early (days 2–4) and/or a late (days 5–8) reading is given. Both the number of reacting patients and the
proportion (%) among those tested are given. bThe ratios between all positive reactions to 2.0% and 1.0%.
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to 1.0% formaldehyde was 0.7%, and the highest was
8.5%. For formaldehyde2.0%, the rangewas1.3–11.9%.
The ratios between cases found when patch testing with
2.0% and 1.0% thus ranged from 5 to 1.
Of the 2.0% of positives, 68.9% were female, and of
the 1.0% of positives, 69.7%were female; thus, there was
no sex difference. Regarding the participating clinics, the
relative proportions of formaldehyde-positive males and
females varied (Table 1). The total number of reported
reacting individuals was 258. The number of irritant and
doubtful reactions reported by the participating clinics
varied. The proportions of irritant reactions thus ranged
between 0% for both 1.0% and 2.0%, and 21% for 2.0%,
and 8% for 1.0%. Regardless of reading day, among 39
doubtful reactions to 1%, recorded when two readings
were performed, 17 were positive to 2%, that is, 14%
(17/122) of all the 2% of positives, and 22 were doubtful
or negative (Fig.1). Approximately 10% of all cases were
diagnosed on a second late reading (as defined above)
by 2.0%, and 5% were diagnosed on a second reading
by 1.0%. The proportion of negative, irritant or doubtful
reactions not evaluated on a second reading was ∼ 10%.
In all, 25 cases of contact allergy to quaternium-15
were reported, but only 4 cases had contact allergy to this
substance without reacting positively to formaldehyde
(Table 2).
The analyses of the content of formaldehyde in the
patch test solutions (detection limit 0.00005%) were
performed for three different batches with ranges of
0.99–1.16% and 2.03–2.14%, respectively.
Discussion
As stated above, previous data suggested that 2.0%
formaldehyde detects significantly more contact allergies
than 1.0% (4). In the present multicentre study, the
variation between the participating clinics in the
proportionsofcases foundamongthepatchtestedpatients
was 10-fold, regardless of patch test concentration.
Furthermore, the proportions of additionally found cases
with contact allergy to formaldehyde when 2.0% and
1.0% were compared showed a five-fold variation.
Regardless of these variations, the overall result shows
that significantlymorecasesare foundwhenpatch testing
with 2.0% than when patch testing with 1.0% (3.4%
versus 1.8%; p < 0.001, McNemar’s test).
From the present data, it is difficult to evaluate the
disadvantages of 2.0% as compared with 1.0% with
respect to irritantreactions,as theyvariedgreatlybetween
the participating clinics. Whether the variation depends
on differences in evaluation of the morphology of a test




















Fig. 1. The number of doubtful reactions to 1.0% (wt/vol)
formaldehyde in patients who were read both at days 2–4 and 5–8
that were diagnosed as positive and doubtful/negative to 2.0%
(wt/vol) formaldehyde.
Table 2. Positive reactions to quaternium-15 1% pet. in relation to formaldehyde 2.0% (wt/vol) and 1.0% (wt/vol) in water when tested








Amsterdam, The Netherlands 6 4 4 2
Barcelona, Spain 1 1 1 0
Coimbra, Portugal 2 1 1 0
Copenhagen (Bispebjerg) Denmark 4 2 2 2
Copenhagen (Gentofte) Denmark 2 2 2 0
Helsinki, Finland 0 0 0 0
Leuven, Belgium 1 1 1 0
London, United Kingdom 2 1 2 0
Malmo¨, Sweden 3 3 3 0
Odense, Denmark 2 2 2 0
San Francisco, United States 0 0 0 0
Strasbourg, France 2 2 2 0
Total 25 19 20 4
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if it is taken for granted that the protocol was followed
by the participating clinics, the former explanation is the
more probable. If so, the variation implies that standard-
ization is warranted not only for the dose of the patch test
but also for themorphology of irritant, doubtful andweak
reactions. The results also show, as is the case for many
other contact allergens, the importance of a second late
reading for formaldehyde (10–13).
Formaldehyde is a ubiquitous allergen.When dermati-
tis causedor aggravated by exposure to formaldehyde is to
be prevented, the diagnosis of contact allergy to formalde-
hyde must be as correct as possible. It has been shown
that a significant number of persons who react to 2.0%
but not to 1.0% develop dermatitis when exposed to a
moisturizer containing formaldehyde (5). On the basis of
these data and the results of this multicentre study, it can
be suggested that 2.0% (wt/vol) formaldehyde in water
should be used in routine patch testing in the baseline
series.
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